The potential for using risk models in future lung cancer screening trials

F1000 Medicine Reports

Volumn 2, Issue 1, 2010, Pages

  Field, John K ^a   Raji, Olaide Y ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG CANCER; MEDICAL DECISION MAKING; PNEUMONIA; REVIEW; SMOKING CESSATION PROGRAM;

EID: 77955064321     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M2-38     Document Type: Review

References (40)

1. Hirsch FR, Lippman SM: Advances in the biology of lung cancer chemoprevention. J Clin Oncol 2005, 23:3186-97.
2. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
3. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH; Eastern Cooperative Oncology Group: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002, 346:92-8.
4. Coleman MP, Rachet B, Woods LM, Mitry E, Riga M, Cooper N, Quinn MJ, Brenner H, Estève J: Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004, 90:1367-73.
5. Ganti AK, Mulshine JL: Lung cancer screening: panacea or pipe dream? Ann Oncol 2005, 16(Suppl 2):ii215-9.
6. Field JK, Duffy SW: Lung cancer screening: the way forward. Br J Cancer 2008, 99:557-62.
7. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP: Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999, 354:99-105. (Pubitemid 29313143)
8. Mulshine JL, Sullivan DC: Clinical practice. Lung cancer screening. N Engl J Med 2005, 352:2714-20.
9. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, van Iersel CA, van den Bergh KA, van 't Westeinde S, van der Aalst C, Thunnissen E, Xu DM, Wang Y, Zhao Y, Gietema HA, de Hoop BJ, Groen HJ, de Bock GH, van Ooijen P, Weenink C, Verschakelen J, Lammers JW, Timens W, Willebrand D, Vink A, Mali W, de Koning HJ: Management of lung nodules detected by volume CT scanning. N Engl J Med 2009, 361:2221-9.
10. van Klaveren RJ, de Koning HJ, Mulshine J, Hirsch FR: Lung cancer screening by spiral CT. What is the optimal target population for screening trials? Lung Cancer 2002, 38:243-52.
11. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R: Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000, 321:323-9.
12. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, Hsieh LJ, Begg CB: Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003, 95:470-8.
13. Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Dong Q, Shete S, Etzel CJ: A risk model for prediction of lung cancer. J Natl Cancer Inst 2007, 99:715-26.
14. Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK: Lung cancer risk prediction: a tool for early detection. Int J Cancer 2007, 120:1-6. (Pubitemid 44901910)
15. Duffy SW, Raji OY, Agbaje OF, Allgood PC, Cassidy A, Field JK: Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer. Expert Rev Anticancer Ther 2009, 9:1467-72.
16. Field JK: Lung cancer risk models come of age. Cancer Prev Res 2008, 1:226-8.
17. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Chen C, Goodman G, Field JK, Liloglou T, Xinarianos G, Cassidy A, McLaughlin J, Liu G, Narod S, Krokan HE, Skorpen F, Elvestad MB, Hveem K, Vatten L, Linseisen J, et al.: A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008, 452:633-7.
18. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, Sullivan K, Matakidou A, Wang Y, Mills G, Doheny K, Tsai YY, Chen WV, Shete S, Spitz MR, Houlston RS: Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008, 40:616-22.
19. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, Stacey SN, Bergthorsson JT, Thorlacius S, Gudmundsson J, Jonsson T, Jakobsdottir M, Saemundsdottir J, Olafsdottir O, Gudmundsson LJ, Bjornsdottir G, Kristjansson K, Skuladottir H, Isaksson HJ, Gudbjartsson T, Jones GT, Mueller T, Gottsäter A, Flex A, Aben KK, de Vegt F, et al.: A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008, 452:638-42.
20. Spitz MR, Etzel CJ, Dong Q, Amos CI, Wei Q, Wu X, Hong WK: An expanded risk prediction model for lung cancer. Cancer Prev Res 2008, 1:250-4.
21. Baker SG: Putting risk prediction in perspective: relative utility curves. J Natl Cancer Inst 2009, 101:1538-42.
22. Vickers AJ, Cronin AM, Elkin EB, Gonen M: Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak 2008, 8:53.
23. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-72; discussion 207-12.
24. Pepe MS, Janes HE: Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer. J Natl Cancer Inst 2008, 100:978-9.
25. Liang HY, Li XL, Yu XS, Guan P, Yin ZH, He QC, Zhou BS: Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer 2009, 125:2936-44.
26. Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM: Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst 2009, 101:554-9.
27. Richards MA: The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. Br J Cancer 2009, 101(Suppl 2):S1-4.
28. The Lancet: General practitioner or computerised algorithm? Lancet 2010, 375:94.
29. Freedman AN, Seminara D, Gail MH, Hartge P, Colditz GA, Ballard-Barbash R, Pfeiffer RM: Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst 2005, 97:715-23. (Pubitemid 40872378)
30. Reilly BM, Evans AT: Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 2006, 144:201-9.
31. Ashton M, Mimnagh C, Forrest D, Field J: A pilot study to explore lung cancer early detection and clinical intervention in a primary care setting in Knowsley, Merseyside. J Thorac Oncol 2008, 3(Suppl 7):S179-257 Abstract PP24.
32. NIHR Health Technology Assessment Programme - Details of completed HTA project: UK Lung Cancer Screening Trial (UKLS) - Feasibility study and protocol development. [http://www.hta.ac.uk/1752]
33. van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, Prokop M, Habbema JD, Oudkerk M, van Klaveren RJ: Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007, 120:868-74.
34. Pedersen JH, Dirksen A, Olsen JH: [Screening for lung cancer with low-dosage CT]. Ugeskr Laeger 2002, 164:167-70.
35. Picozzi G, Paci E, Lopez Pegna A, Bartolucci M, Roselli G, De Francisci A, Gabrielli S, Masi A, Villari N, Mascalchi M: Screening of lung cancer with low dose spiral CT: results of a three year pilot study and design of the randomised controlled trial "Italung-CT". Radiol Med (Torino) 2005, 109:17-26.
36. Infante M, Lutman FR, Cavuto S, Brambilla G, Chiesa G, Passera E, Angeli E, Chiarenza M, Aranzulla G, Cariboni U, Alloisio M, Incarbone M, Testori A, Destro A, Cappuzzo F, Roncalli M, Santoro A, Ravasi G; DANTE Study Group: Lung cancer screening with spiral CT Baseline results of the randomized DANTE trial. Lung Cancer 2008, 59:355-63.
37. Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, Chagué D, Laurent F, Martinet Y, Beigelman-Aubry C, Blanchon F, Revel MP, Friard S, Rémy-Jardin M, Vasile M, Santelmo N, Lecalier A, Lefébure P, Moro-Sibilot D, Breton JL, Carette MF, Brambilla C, Fournel F, Kieffer A, Frija G, Flahault A; Dépiscan Group: Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 2007, 58:50-8.
38. Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, Ascher S, Bailey W, Brewer B, Church T, Engelhard D, Ford M, Fouad M, Freedman M, Gelmann E, Gierada D, Hocking W, Inampudi S, Irons B, Johnson CC, Jones A, Kucera G, Kvale P, Lappe K, Manor W, Moore A, Nath H, Neff S, Oken M, Plunkett M, et al.; Lung Screening Study Research Group: Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005, 47:9-15.
39. Ford LG, Minasian LM, McCaskill-Stevens W, Pisano ED, Sullivan D, Smith RA: Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA Cancer J Clin 2003, 53:82-101. (Pubitemid 36411041)
40. National Cancer Institute - U.S. National Institutes of Health: National Lung Screening Trial (NLST). [http://www.cancer.gov/nlst]